Preclinical studies have shown marked decreases in 5-HT1A receptor expression across various regions sampled from human AD brains (Bowen et al., 1983; Cross et al., 1984; Lai et al., 2003). The gene discussed is HTR1A; the disease is Alzheimer disease.